Alphala Co., Ltd.

Taiwan Semiconductor Manufacturing Comp. Ltd.

Yen-Fu Chen

Cheng-Ho Chung

Shi-Liang Tseng

Chi On Chui

Kuei-Lun Lin

Yung-Ning Yang

Da-Yuan Lee

Xiong-Fei Yu

Chia-Yuan Chang

Po-Ting Lin

Tsung-Da Lin

Jian-Bin Lee

A semiconductor device a method of forming the same are provided. The method includes forming a fin extending from a substrate and forming a gate dielectric layer along a top surface and sidewalls of the fin. A first thickness of the gate dielectric layer along the top surface of the fin is greater than a second thickness of the gate dielectric layer along the sidewalls of the fin.

Fin field effect transistor having conformal and non-conformal gate dielectric layers

A method for forming a semiconductor device structure is provided. The method includes providing a substrate and an insulating layer over the substrate. The method includes depositing a gate dielectric layer over the insulating layer and in the wide trench and the narrow trench using an atomic layer deposition process. The method includes forming a gate electrode layer over the gate dielectric layer. The method includes removing the gate dielectric layer and the gate electrode layer outside of the wide trench and the narrow trench.

Method for forming semiconductor device structure with gate

Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: (I), in which each of variables R, R, R, R, R, A, A, A, A, X and Y is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same. 

Amide compounds and use thereof

Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: Formula (I), in which each of variables L, R, R, Y, Z, Zand Zis defined herein. Also disclosed is a method for treating a cancer with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same. 

Compound and pharmaceutical composition containing the same

Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof, in which each of variables R, R, L, and Z is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same. 

Growing community of inventors

Taipei, Taiwan

Yen-Fu Chen